NIH-funded research U01 cooperative agreement

Ugandan Schistosomiasis Research Center exploring why some people get severe disease

Official title: Uganda Schistosomiasis Multidisciplinary Research Centre (U-SMRC)

Funded at Uganda Virus Research Institute · NIH-11415018 · Data updated 2026-11-12

Scientists in Uganda are studying how Schistosoma mansoni causes serious illness and how to prevent it, focusing on both children and adults in high-risk areas.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUganda Virus Research Institute
NIH-funded
Lab location1 site (Entebbe, Uganda)
Project startMay 9, 2022
Project endApril 30, 2027
Funding year2026
Award (this year)$246,568
NIH project number5U01AI168609-05
Project IDNIH-11415018 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include preschool-age children in the Lake Albert region and adults with a history of schistosomiasis exposure in Uganda.

Less likely to help

Individuals not exposed to Schistosoma mansoni or not in the study regions may not directly benefit.

What this research studies

The Uganda Schistosomiasis Multidisciplinary Research Center (U-SMRC) is creating a Uganda-based network to study schistosomiasis and build local capacity. Researchers will follow preschool-age children in two Lake Albert regions to see how early immune responses develop and contribute to severe disease, and they will compare adults with chronic exposure to identify risk factors. The work combines human subjects, parasite biology, and snail hosts to understand multiple steps in disease progression. This is a collaborative effort led by the Uganda Virus Research Institute in Entebbe with local partners to inform better prevention and control strategies.

Why it matters

Potential benefit: If successful, the project could lead to improved prevention and treatment approaches that reduce severe schistosomiasis in Uganda and similar settings.

How similar studies have gone: Previous schistosomiasis research has identified factors linked to severe disease, but this project aims to uncover region-specific biological determinants and prevention strategies in Uganda.

Where this research is happening

  • Uganda Virus Research Institute
    Entebbe, Uganda
    Active

Researchers

  • Principal investigator: Elliott, Alison — Uganda Virus Research Institute
  • Study coordinator: Elliott, Alison

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.